Nothing Special   »   [go: up one dir, main page]

ES2037257T3 - Procedimiento de obtencion de los derivados de n-aminobutil y n-fenil arilamidas. - Google Patents

Procedimiento de obtencion de los derivados de n-aminobutil y n-fenil arilamidas.

Info

Publication number
ES2037257T3
ES2037257T3 ES198888401741T ES88401741T ES2037257T3 ES 2037257 T3 ES2037257 T3 ES 2037257T3 ES 198888401741 T ES198888401741 T ES 198888401741T ES 88401741 T ES88401741 T ES 88401741T ES 2037257 T3 ES2037257 T3 ES 2037257T3
Authority
ES
Spain
Prior art keywords
group
alkyl
hydrogen
naftio
alcoxi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198888401741T
Other languages
English (en)
Inventor
Christian Hoornaert
Jean-Claude Muller
Nigel Beeley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Application granted granted Critical
Publication of ES2037257T3 publication Critical patent/ES2037257T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/67—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/75—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)

Abstract

COMPUESTOS QUE RESPONDEN A LA FORMULA GENERAL (I), DONDE X ES UN ATOMO DE HIDROGENO O DE HALOGENO, O UN GRUPO TRIFLUOROMETILO, ALQUILO C1-C4 O ALCOXI C1-C4; R1 ES UN GRUPO ALQUILO RECTO O RAMIFICADO C2-C8, UN GRUPO CICLOALQUILO C3-C5 O UN GRUPO CICLOALQUILMETILO, CUYO CICLO ES C3-C5, TOMADO AISLADAMENTE, REPRESENTA UN ATOMO DE HIDROGENO O UN GRUPO ALQUILO C1-C4; R3, TOMADO AISLADAMENTE, REPRESENTA UN ATOMO DE HIDROGENO O UN GRUPO ALQUILO C1-C4, UN GRUPO FENILALQUILO, EVENTUALMENTE SUSTITUIDO, O UN GRUPO PIRIDINILALQUILO; O BIEN R2 Y R3 JUNTOS REPRESENTAN CON EL ATOMO DE NITROGENO QUE LOS CONTIENE, UN CICLO PIRROLIDINILO, PIPERIDINILO, MORFOLINILO, PERHIDROTIAZINILO, PIPERAZINILO O METIL-4-PIPERAZINILO; Y AR REPRESENTA UN GRUPO FENILO, QUE TIENE, EVENTUALMENTE, 1-3 SUSTITUYENTES ELEGIDOS ENTRE LOS ATOMOS DE HALOGENO, LOS GRUPOS ALQUILO C1-C4, ALCOXI C1-C4, TRIFLUOROMETILO, NITRO Y CIANO, O UN GRUPO NAFTILO, PIRIDINILO, QUINOLEINILO O ISOQUINOLEINILO. APLICACION EN TERAPEUTICA.
ES198888401741T 1987-07-16 1988-07-05 Procedimiento de obtencion de los derivados de n-aminobutil y n-fenil arilamidas. Expired - Lifetime ES2037257T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8710026A FR2618149B1 (fr) 1987-07-16 1987-07-16 Derives de n-aminoalkyl n-phenyl arylamides, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
ES2037257T3 true ES2037257T3 (es) 1993-06-16

Family

ID=9353186

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198888401741T Expired - Lifetime ES2037257T3 (es) 1987-07-16 1988-07-05 Procedimiento de obtencion de los derivados de n-aminobutil y n-fenil arilamidas.

Country Status (21)

Country Link
US (2) US5001159A (es)
EP (1) EP0300865B1 (es)
JP (1) JPH0794417B2 (es)
KR (1) KR890001957A (es)
AR (1) AR247380A1 (es)
AT (1) ATE73762T1 (es)
AU (1) AU600376B2 (es)
CA (1) CA1306748C (es)
CS (1) CS405391A3 (es)
DE (1) DE3869257D1 (es)
DK (1) DK397388A (es)
ES (1) ES2037257T3 (es)
FI (1) FI883377A7 (es)
FR (1) FR2618149B1 (es)
GR (1) GR3004458T3 (es)
HU (1) HU198903B (es)
IE (1) IE61843B1 (es)
IL (1) IL87089A (es)
NO (1) NO174959C (es)
NZ (1) NZ225430A (es)
ZA (1) ZA885150B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116851A (en) * 1990-01-26 1992-05-26 E. R. Squibb & Sons, Inc. Pharmaceutical composition and method for treating cardiovascular diseases using substituted anilides and sulfonamides
FR2694557B1 (fr) * 1992-08-05 1994-09-23 Synthelabo Dérivés de tétrahydronaphtalène, leur préparation, et leur application en thérapeutique.
FR2705675B1 (fr) * 1993-05-27 1996-05-03 Smithkline Beecham Labo Pharma Nouveaux composés, leur procédé de préparation et leur utilisation en tant que médicaments.
WO1994027971A1 (en) * 1993-05-27 1994-12-08 Smithkline Beecham Laboratoires Pharmaceutiques Anti-arrhythmic n-substituted 3-benzazepines or isoquinolines
FR2706895A1 (en) * 1993-06-22 1994-12-30 Synthelabo Tetrahydroisoquinoline derivatives, their preparation and their application in therapeutics
FR2706894A1 (en) * 1993-06-22 1994-12-30 Synthelabo N-Phenyl-N-(piperidinoalkyl)arylamide derivatives, their preparation and their application in therapeutics
FR2715652B1 (fr) * 1994-02-03 1996-03-22 Synthelabo Dérivés de N-[3-[(2,3-dihydro-1H-inden-2-yl)alkyl-amino]propyl]-N-phényl-5,6,7,8-tétrahydronaphtalène-2-carboxamide leur préparation et leur application en thérapeutique.
TW281667B (es) * 1994-02-03 1996-07-21 Synthelabo
FR2715654B1 (fr) * 1994-02-03 1996-03-22 Synthelabo Dérivé de N-[3-(1,2,3,4-tétrahydroisoquinoléin-2-yl)-propyl]-N-phényl-5,6,7,8-tétrahydronaphtalène-2-carboxamide, leur préparation et leur application en thérapeutique.
WO1995024390A1 (en) * 1994-03-11 1995-09-14 Smithkline Beecham Plc Novel phenyl(-alkyl/alkoxy)-1-aminoalkyl-substituted piperidines and pyrrolidines as calcium channel antagonists
WO1996027595A1 (en) * 1995-03-08 1996-09-12 Smithkline Beecham Laboratoires Pharmaceutiques Heterocyclycarboxamides and other compounds for the treatment of the cardiac arrhythmias
GB9708694D0 (en) * 1997-04-30 1997-06-18 Smithkline Beecham Plc Compounds
GB9708805D0 (en) 1997-05-01 1997-06-25 Smithkline Beecham Plc Compounds
GB9810876D0 (en) 1998-05-20 1998-07-22 Smithkline Beecham Plc Compounds
JP2002527433A (ja) 1998-10-08 2002-08-27 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー ドーパミンｄ３受容体のモジュレーター（抗精神病薬）として有用なテトラヒドロベンズアゼピン誘導体
KR20010111594A (ko) 1999-05-10 2001-12-19 로즈 암스트롱, 크리스틴 에이. 트러트웨인 방향족 아미드
US7955170B2 (en) * 2004-07-30 2011-06-07 Igt Providing non-bingo outcomes for a bingo game

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1232787A (es) * 1967-08-08 1971-05-19
FR8120M (es) * 1968-12-26 1970-08-03
US4808624A (en) * 1984-06-28 1989-02-28 Bristol-Myers Company Pharmacologically active substituted benzamides

Also Published As

Publication number Publication date
HUT47079A (en) 1989-01-30
CS405391A3 (en) 1992-09-16
FR2618149A1 (fr) 1989-01-20
ZA885150B (en) 1989-03-29
DK397388D0 (da) 1988-07-15
NO883122L (no) 1989-01-17
IE882179L (en) 1989-01-16
US5075325A (en) 1991-12-24
AR247380A1 (es) 1994-12-29
NO174959C (no) 1994-08-10
FI883377A0 (fi) 1988-07-15
JPS6434950A (en) 1989-02-06
FI883377A7 (fi) 1989-01-17
IL87089A0 (en) 1988-12-30
AU600376B2 (en) 1990-08-09
CA1306748C (en) 1992-08-25
US5001159A (en) 1991-03-19
ATE73762T1 (de) 1992-04-15
NZ225430A (en) 1990-01-29
AU1907788A (en) 1989-01-19
NO883122D0 (no) 1988-07-13
KR890001957A (ko) 1989-04-06
IE61843B1 (en) 1994-11-30
DE3869257D1 (de) 1992-04-23
NO174959B (no) 1994-05-02
FR2618149B1 (fr) 1989-09-22
IL87089A (en) 1993-02-21
DK397388A (da) 1989-02-09
HU198903B (en) 1989-12-28
JPH0794417B2 (ja) 1995-10-11
EP0300865B1 (fr) 1992-03-18
EP0300865A1 (fr) 1989-01-25
GR3004458T3 (es) 1993-03-31

Similar Documents

Publication Publication Date Title
ES2037257T3 (es) Procedimiento de obtencion de los derivados de n-aminobutil y n-fenil arilamidas.
TW370450B (en) Substituted 1H-3-aryl-pyrrolidine-2,4-dione derivatives
ES473570A1 (es) Un procedimiento para la preparacion de compuestos heteroci-clicos.
MX171822B (es) Proceso quimico
DK164452C (da) 3-nitroquinolinderivat
ES474592A1 (es) Procedimiento para la preparacion de derivados de imidazoli-nina
ES2221440T3 (es) Derivados de acido aminofenoxiacetico como neuroprotectores.
ES470155A1 (es) Un procedimiento para la obtencion de derivados de espiroa- mina
ES2044982T3 (es) Un procedimiento para preparar un compuesto que inhibe las enzimas lipoxigenasas.
ES2039361T3 (es) Derivados de 3-vinil- y 3-etinil-beta-carbolinas, su preparacion y su utilizacion como medicamentos.
DK165953C (da) Fremgangsmaade til fremstilling af 2,3-dihydrobenzofuranderivater
ES8604543A1 (es) Procedimiento para la obtencion de derivados piperazinicos
ES2037011T3 (es) Procedimiento para la preparacion de nuevos derivados de benzofuran-2-il-imidazol.
ES474677A1 (es) Un procedimiento para la produccion de pirazinobenzosazeni- nos
ES2055804T3 (es) Procedimiento de preparacion de nuevas meta-fenilendiaminas sustituidas con trialcoxi.
ES2081858T3 (es) Compuestos de beta-fenoxinitrilo.
CO4940417A1 (es) DERIVADOS DE 2,3-DIHIDROFURO[3,2-b]PIRIDINA, SU PREPARACION Y SU APLICACION EN TERAPEUTICA
ES2038684T3 (es) Procedimiento de preparacion de derivados de octahidroindol y de compuestos intermedios de su preparacion.
ES2077042T3 (es) Derivados de benzoxazina, derivados de benzotiazina y herbicidas que comprenden los mismos.
ES471403A1 (es) Un procedimiento de preparacion de derivados de la tienopi- ridina
ES462890A1 (es) Procedimiento para la preparacion de 1-(n-acil-carbamoil)-2-cianazi-ridinas con efecto cancerostatico y estimulador de inmunidad.
ES2059550T3 (es) Derivados de la bencimidazola, su preparacion y su aplicacion en terapeutica.
ES2045282T3 (es) Un procedimiento para la preparacion de antraciclinona 4-sustituida.
ES470751A1 (es) Procedimiento de preparacion de nuevas piridazinilhidrazonasy de sus sales farmaceuticamente aceptables
ES2036583T3 (es) Iminooxazolidinas, procedimiento de preparacion y metodo de uso.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 300865

Country of ref document: ES